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Abstract
Background: ABCB5 is a member of the ABC protein superfamily, which includes the transporters ABCB1, ABCC1 and ABCG2
responsible for causing drug resistance in cancer patients and also several other transporters that have been linked to
human disease. The ABCB5 full transporter (ABCB5.ts) is expressed in human testis and its functional significance is presently
unknown. Another variant of this transporter, ABCB5 beta posses a ‘‘half-transporter-like’’ structure and is expressed in
melanoma stem cells, normal melanocytes, and other types of pigment cells. ABCB5 beta has important clinical implications,
as it may be involved with multidrug resistance in melanoma stem cells, allowing these stem cells to survive
chemotherapeutic regimes.
Methodology/Principal Findings: We constructed and examined in detail topological structures of the human ABCB5
protein and determined in-silico the cSNPs (coding single nucleotide polymorphisms) that may affect its function.
Evolutionary analysis of ABCB5 indicated that ABCB5, ABCB1, ABCB4, and ABCB11 share a common ancestor, which began
duplicating early in the evolutionary history of chordates. This suggests that ABCB5 has evolved as a full transporter
throughout its evolutionary history.
Conclusions/Significance: From our in-silco analysis of cSNPs we found that a large number of non-synonymous cSNPs
map to important functional regions of the protein suggesting that these SNPs if present in human populations may play a
role in diseases associated with ABCB5. From phylogenetic analyses, we have shown that ABCB5 evolved as a full
transporter throughout its evolutionary history with an absence of any major shifts in selection between the various
lineages suggesting that the function of ABCB5 has been maintained during mammalian evolution. This finding would
suggest that ABCB5 beta may have evolved to play a specific role in human pigment cells and/or melanoma cells where it is
predominantly expressed.
Citation: Moitra K, Scally M, McGee K, Lancaster G, Gold B, et al. (2011) Molecular Evolutionary Analysis of ABCB5: The Ancestral Gene Is a Full Transporter with
Potentially Deleterious Single Nucleotide Polymorphisms. PLoS ONE 6(1): e16318. doi:10.1371/journal.pone.0016318
Editor: Hendrik W. van Veen, University of Cambridge, United Kingdom
Received October 5, 2010; Accepted December 17, 2010; Published January 27, 2011
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: deanm@mail.nih.gov
. These authors contributed equally to this work.
Introduction
ABCB5 is a member of the ATP-binding cassette (ABC)
superfamily of transporters that function in the ATP-dependent
transport of structurally diverse molecules. A number of
transporters in this family are implicated in multidrug resistance
and are recognized causes for the failure of cancer chemotherapy
[1,2,3].
These transporters represent the largest family of transmem-
brane proteins and are classified into seven families (A–G) in
humans, based on the sequence and organization of the
nucleotide-binding domain [4]. The conserved nucleotide binding
domains of these transporters drive transport, whereas the more
variable transmembrane domains create the translocation path-
way, providing safe passage for a diverse variety of substrates
[5].
The human genome contains 48 ABC genes; 16 of these have
known functions, while 14 have been associated with human
disease states [6]. ABCB5 is a member of the B branch of the ABC
transporter superfamily which contains 11 members and includes
the multidrug transporter P-glycoprotein (ABCB1), along with the
bile salt exporter pump ABCB11 and the phosphatidylcholine
transporter ABCB4 [7]. A number of distinct forms of ABCB5
have been shown to be expressed in various tissue types, including,
but not limited to, melanocytes, melanoma cells, testis, mammary
tissue, and retinal pigmented epithelium, [8,9,10,11]. ABCB5 has
also been found to be expressed at the transcriptional level in a
number of cancer subtypes, including malignant melanoma, breast
cancer, colorectal cancer and hepatocellular carcinoma
[9,12,13,14], and also has been linked to leukemia [15]. More
importantly, it has been shown that this transporter may be
expressed in melanoma stem cells which posses the CD133
+
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is also indicated to be a metastatic melanoma progression marker,
and it is suggested that this transporter has a role in the regulation
of progenitor cell fusion [9,16]. Four major forms of human
ABCB5 have been documented: ABCB5.a (812 aa, also known as
beta form), ABCB5.e (134aa), ABCB5.f (131 aa, ABCB5 alpha
form) and ABCB5.ts (1257aa, testis-specific) [17]. Of these,
ABCB5.ts is a putative full transporter expressed specifically in
the human testis. ABCB5.a is a half-transporter form expressed in
melanocytes and melanoma. ABCB5.f (alpha) is the smallest
predicted protein form (15 kD) and has been hypothesized to have
a regulatory rather than a transport role [11].
Among the substrates of this rather elusive transporter are
doxorubicin and rhodamine 123 [8,13,14]. There is evidence in
the literature that shows inhibition of ABCB5 either at the protein
or mRNA level can inhibit doxorubicin transport and also
sensitize melanoma and liver cancer stem cells to the drug
[9,14]. To date, however, no exhaustive studies have been carried
out regarding the organization, topology, evolution, and genetic
variations of this transporter, leaving a knowledge gap in the field
regarding basic questions such as: Does ABCB5 function as a full
transporter or by dimerization of half-transporter units? How is
this transporter structurally organized? How did this transporter
evolve and how far back in time can its ancestry be traced? And
finally, could genetic variants of this transporter potentially affect
its functional role?
We have tried to bridge this gap by carrying out exhaustive in
silico phylogenetic and bioinformatics studies, which indicate that
this transporter evolved as a full, rather than a half-transporter,
which implies that it functions as a full transporter in certain
human tissues or developmental stages. The sequence and
topological analysis of the half-transporter in humans shows a
unique predicted topology in which the beta form of the
transporter has two NBDs (nucleotide binding domains) instead
of one, and the first NBD lacks the Walker A region, indicating
that this NBD may not be completely functional. A number of
single nucleotide polymorphisms (SNPs; 879 in total from NCBI
dbSNP) have also been detected in/near this gene. Ten of these
are non-synonymous (amino-acid changing) cSNPs, which may
affect function. Non-synonymous cSNPs were present in key
regions of the gene, including TMDs (transmembrane domains),
NBDs, extracellular loops, and the intracellular loops. SNPs in
ABC transporters have been reported to play an important role in
patients’ response to medication and also to play a pivotal factor in
risk for disease [18].
Results
Prediction of topological structure with HMMTOP of the
full-length ABCB5 indicates that it contains 12
transmembrane alpha helices, while ABCB5 beta has 6
We determined the topology of the testis-specific full transporter
and the beta form because they are most likely to have transporter
functions. We constructed models using HMMTOP and displayed
them using the program TOPO2. In the full length protein
HMMTOP predicted the presence of the conventional 12 TMs
with the 2 NBDs, which represents the accepted model for most
full transporters (fig. 1A). For ABCB5 beta we found that the
transporter had 6 predicted TMs, one complete NBD and one
incomplete NBD. Both the NBD’s are predicted to be located in
the cytoplasm (fig. 1B).
Traditionally transporter topology has been determined using
hydrophobicity plots which determine the locations of the
hydrophobic and hydrophilic regions of the transporter (based
on the properties of the amino acids) which correspond to the TM
regions, extracellular/cytoplasmic regions respectively. Hydropho-
bicity plots for the full transporter were constructed with
TMHMM which predicted 8 TM helices (data not shown).
Hydrophobicity plots were also constructed for the beta form with
TMHMM. The beta form was predicted to have 5 TM helices and
the NBD was predicted to be on the extracellular surface, however
when we aligned the ABCB5 beta sequence to human Pgp we
found that the topology predicted that the transporter would have
6TM helices instead of 5 (data not shown). It is most likely that the
structure predicted by HMMTOP is the closest prediction since it
conforms to the basic structure of most ABC transporters,
however, the likelihood that this transporter may have a unique
structure cannot be completely ruled out.
Functional motif analysis showed that ABC transporter
motifs and potential membrane-targeting residues were
present in ABCB5
The Motif Scan program was applied for predicting functional
motifs within the human full-length ABCB5 amino acid sequence.
The analysis revealed the presence of 2 ABC_transporter_2 motifs
at amino acids 386–622 and 1015–1253; and 2 ABC_ membrane
motifs at amino acids 48–339 and 692–968 (fig. 1A). The beta
form showed 2 ABC_transporter_2 domain amino acids 2–177,
570–808, and one ABC_ membrane domain amino acids 247–523
(fig. 1B). Motif Scan was also used to detect functional domains.
Several phosphorylation sites and glycosylation sites were present,
which may be important for targeting of the protein to the
membrane [19]. In the full transporter, 14 N-glycosylation sites
were found, out of which 2 sites (aa 85–88, 91–94) may be
important for targeting of the transporter to the membrane
(fig. 1A). In the beta form, 6 N-glycosylation sites were found, out
of which one site (amino acids 374–377) may be important for
targeting of the transporter to the membrane (fig. 1B). A P-loop
(Walker A) was detected at aa’s 605–612 [AG]-x[4]-G-K-[ST] =
(GSSGCGKST). The P-loop in ABC transporters is important in
ATP binding and hydrolysis.
Coiled-coil domain analysis of ABCB5 beta suggests that
potential dimerization motifs are present at the
N-terminal region
The coiled–coil structure is a highly prevalent protein structural
motif [20] and is thought to be present in approximately 5–10% of
protein sequences [21]. Coiled–coils can have a stabilization
function and are often involved in cellular signaling, protein
interaction, and other significant cellular processes [20]. Two or
more alpha-helices wound around each other in a symmetrical
manner make up the basic ‘‘coiled–coil’’ structure [22]. Coiled-
coils have been predicted to exist at the N-terminus of the goat
half-transporter ABCG2 and the investigators have discussed the
possibility that these domains may be involved in oligomerization
functions [23]. A unique feature of the ABCB5 beta form is that it
has 2 NBDs (first NBD lacking the Walker A) rather than the
conventional 1 NBD, which is usually present in half-transporters.
Due to this unusual configuration, we decided to investigate the
presence of dimerization motifs in ABCB5—such as coiled–coil
structures—using Marcoil, Coils and Psipred. Marcoil (v1.0)
predicted coiled–coil domains in the N-terminal region of ABCB5
beta at a stringency of 1% in the three following regions: positions
46–58, 112–124, and 176–191. Coils (v1.0) predicted coiled–coil
regions at or above 80% probability in 2 significant regions
spanning amino acids 46–60 and 178–191 (fig. 2). These regions
are similar to two of the coiled–coils predicted by Marcoil. Cross-
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PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e16318Figure 1. Predicted topological structures of ABCB5. A. Topological structure of the ABCB5 full transporter. The figure depicts 12
transmembrane alpha helices and 2 nucleotide-binding domains. The 2 ABC_membrane motifs, amino acids 48–339 and 692–968, are highlighted in
orange and the 2 ABC_transporter_2 motifs, amino acids 386–622 and 1015–1253, are highlighted in purple. The 2 N-glycosylation sites, amino acids
85–88 and 91–94, which may be important for targeting of the transporter to the membrane, are highlighted in blue. The topological structure was
determined using HMMTOP and displayed using the TOPO2 software. Functional motifs were determined using MOTIFSCAN. B. Topology of
ABCB5 beta. Topology was determined with HMMTOP and displayed using TOPO2. Diagram depicts 6 transmembrane alpha helices and 2
nucleotide-binding domains. One ABC_membrane domain, amino acids 247–523, is shown in orange and the 2 ABC_transporter_2 domains, amino
acids 2–177 and 570–808, are depicted in purple.
doi:10.1371/journal.pone.0016318.g001
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domain extending from amino acids 177–193. Taken together,
these results suggest that there is at least one coiled–coil motif in
the N-terminal region of ABCB5. The coiled–coil motif may be
used to control dimerization/oligomerization in different types of
proteins. The coiled–coil is formed by the component helices
coming together to bury their hydrophobic ends and form a super
coil. Coiled–coil motifs are associated with different functions in
proteins and thus may be very important to understand the
functionality of the protein [19]. In the case of ABCB5 beta, they
might be viewed as potential dimerization sites, which function to
structurally bridge the potential half-transporter monomers to
form the dimeric full transporter.
In ABCB5.ts 3 coiled coils in the N-terminus were also detected
using the program Coils, spanning the amino acids 259-278, 490-
505 and 621-636 giving rise to the speculation that possibly the
smaller variant form of ABCB5 could be interacting with the
coiled-coiled domains of the full transporter and may act in a
dominant negative manner. Potential coiled-coil domains were
also detected in the N-terminus of the B-family transporters
ABCB1, ABCB4 and ABCB11(data not shown) which are the
three transporters most closely related to ABCB5 suggesting that
these domains are conserved in the B-family members closely
related to ABCB5.
Ten non-synonymous cSNPs are present in ABCB5 beta,
while ABCB5.ts has 23
The ABCB5 full transporter gene is located on chromosome
7p21, spans 28 exons and 141.8kb of genomic DNA. This gene
encodes 11 different isoforms as depicted in ENSEMBL (fig. 3).
The ABCB5 beta gene is located on chromosome 7p21, spans 19
exons and 108 kb of genomic DNA [8]. SNPs in the transporter
sequence were identified in the dbSNP database, and the cSNPs
were mapped to the topological model of ABCB5 beta using the
program TOPO2 (fig. 4A).
ABCB5 beta has 10 non-synonymous cSNPs documented by
dbSNP. These are represented by ID numbers: rs34603556,
rs2301641, rs13222448, rs35885925, rs17143304, rs6461515,
rs60197951, rs59334881, and rs58795451. Using our knowledge-
base of ABC transporters and the location of the SNPs on the
protein, we compiled a list of the functional importance of these
SNPs in regard to the protein (Table 1). From the table it can be
seen that a number of the SNPs, rs2301641, rs13222448, and
rs1143304, may affect signaling. rs58795451, rs59334881, and
rs58795451 are located in the NBD; hence, they may be associated
with aberrant ATP binding or hydrolysis. Only 1 SNP, rs6461515,
is located within the substrates sites. Since this SNP may
potentially affect substrate specificity, it may be functionally
important in certain populations.
There are 23 non-synonymous cSNPs in the full transporter
form of ABCB5.ts, and these are depicted in the protein (fig. 4B).
The putative function of these residues is shown in Table 2. Of
particular note is rs76179099, which would create a premature
stop codon in the protein and may give rise to a truncated ABCB5
protein. The allele frequency for this SNP in a sample Yoruban
(West African) population is 0.940 for the A allele (major allele)
and 0.06 for the T allele (minor/SNP allele); data from dbSNP.
Functional analysis of cSNPs with Panther and SIFT
(Sorting Intolerant from Tolerant) predicts that most of
these SNPs might be deleterious to transporter function
The potential significance of these SNPs was determined using
Panther, SIFT and our knowledge base of ABC transporters. The
results are outlined in Table 3 and 4.
The Panther software calculates sub psec scores - substitution
position-specific evolutionary conservation. It aligns the sequence
of the transporter in various species, determines which of the
positions are evolutionarily conserved among species, and assigns a
sub psec score. A sub psec score of -3 or less means that the
substitution has probable functional implications. From table 3 it
can be seen that D742G has the lowest score (-8.01712), indicating
a strong probability of functional impact. This agrees well with the
fact that this residue, which is known as the ‘‘D’’ loop residue, has
an important functional role in communicating signals from one
Figure 2. Coiled-coil regions of ABCB5 beta. Coiled-coil regions were calculated using the program COILS. These regions may indicate potential
dimerization motifs in ABCB5 beta. Each alpha helix in a coiled coil is amphipathic, and the pattern of hydrophilic and hydrophobic amino acids
repeats every 7 residues. Since the coiled-coil is a 7 residue heptad the sliding windows are set at multiples of 7, ie 14, 21 and 28 to enable the
structure prediction algorithm to optimally detect the heptads.
doi:10.1371/journal.pone.0016318.g002
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affect ATP hydrolysis by interfering with this signaling. Another
important substitution would be M1T; since this is a start site
substitution, any change in this residue would affect translation
initiation. The SIFT algorithm also identified these substitutions as
deleterious. Panther identified all the substitutions to be deleterious
to the function of ABCB5 beta to some degree, whereas SIFT
identified M1T (rs34603556), D742G (rs58795451), I648T
(rs60197951), and K115E (rs2301641) to be deleterious. I648T is
also located in the NBD, but not in a conserved motif, whereas
K115E, which changes a positively charged amino acid to a
negatively charged one, is located in a cytoplasmic loop and may
be involved in signaling.
Among the ABCB5.ts SNPs (Table 4) C1054W present in
NBD2 had the lowest sub-psec score (-8.89455), indicating that it
was the most deleterious. This SNP would change the amino acid
cysteine to a bulky tryptophan residue, which may affect NBD
structure and function.
The D loop SNP D1187G had a score of -6.60494, indicating
that this could also be deleterious to function (Note: Three of the
residue changes, A20E, K1056E, and K626X, could not be
calculated using Panther because the positions did not align to the
hidden Markov model).
With the aid of SIFT analysis we found that a number of the
substitutions were not tolerated including: F155V, R260K,
Q262K, I369V, D370G, G810V, P996Q, C1054W, K1056E,
E1124K and D1187G.
Phylogenetic and Evolutionary Analysis
A phylogenetic analysis indicates that ABCB5 is most closely
related to the other full transporters, ABCB1, ABCB4, and
ABCB11 (fig. 5). This clade is supported with a Bayesian posterior
probability of 1.0 (i.e., 100%). ABCB1 and 4 are the most closely
related, followed by ABCB5, with ABCB11 as the outgroup to
these, and with all of these nodes supported by high Bayesian
posterior probabilities. The ABCB full transporters originated
from a single gene that is present in non-vertebrates and goes back
as far as Drosophila, C. elegans, and yeast. ABCB11 orthologs are
present in non-mammals such as Xenopus, birds, and reptiles, while
the duplication event that led to ABCB1 and ABCB4 occurred
after the split of mammals from reptiles and before the most recent
common ancestor of extant mammals, i.e., sometime between 310
million years ago [24,25] and ,235 million years ago [26]. The
only non-mammalian ABCB5 sequence is from Xenopus, which
suggests the ABCB5 gene may have been lost in some lineages
such as birds and reptiles. An analysis of the selection pressure
operating on each site reveals that a large proportion of sites in
each gene are under strong purifying selection, indicating strong
functional constraint (fig. 6).
In phylogenetic analyses the Ka/Ks value is the ratio of the
number of nonsynonymous (amino-acid changing) substitutions
per nonsynonymous site (Ka) to the number of synonymous (non-
amino acid changing) substitutions per synonymous site (Ks). This
can be used as an indicator of selective pressure acting on that
particular gene. Under neutral conditions Ka/Ks is equal to 1, i.e.,
mutations occur randomly and the probability of a nonsynon-
ymous mutation becoming fixed in the population is equal to that
of a synonymous mutation. A Ka/Ks ratio that is significantly less
than 1 indicates that nonsynonymous mutations are less likely to
become fixed in a population. This is known as purifying selection
as potentially deleterious mutations are purged from the
population in order to maintain the sequence of a functionally
important site or region within the coding gene.
The REL analysis of DataMonkey found that 628 of the 1,464
codons in the full-length alignment of ABCB5 were highly
significant for purifying selection. All of the transmembrane
domains and NBDs display low Ka/Ks values, indicating that
these domains have been under functional constraint. The
predicted first NBD of ABCB5 shows comparable levels of
purifying selection to the NBDs of the other ABCB genes,
revealing that it has been functionally constrained throughout
mammalian evolution, and confirming that ABCB5 has evolved as
a full transporter. A comparison between the PAML, DataMon-
key, and Selecton results gave no consensus of any sites adjudged
to be under strong adaptive selection with high probabilities.
However, 2 regions, a cytoplasmic region at the start of the gene
Figure 3. Genomic location (Chromosome 7p21) and multiple isoforms of the ABCB5. The figure depicts eleven ABCB5 splice variants
(from Ensemble).
doi:10.1371/journal.pone.0016318.g003
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number of residues with a Ka/Ks value .1, although these were
not found to be significantly greater than 1.
The GABranch analysis of DataMonkey did not suggest that
any specific lineages were undergoing a shift to adaptive evolution.
The mean Ka/Ks of each branch was estimated to be under 0.5,
indicating that ABCB5 has been undergoing strong to moderate
purifying selection along each lineage. The probability that any of
these branches was undergoing adaptive evolution was estimated
at less than 5%. The only exception was the branch leading to the
6 Laurasiatherian taxa (horse, dog, cow, microbat, hedgehog, and
shrew), which was estimated to have a Ka/Ks value of 0.75; the
probability that this lineage was undergoing positive selection was
adjudged to be 33%. The absence of any major shifts in selection
Figure 4. Non-synonymous cSNPs in ABCB5. A. Topological model of predicted ABCB5 beta protein structure. Diagram showing the
locations of the 10 non-synonymous cSNPs. Black highlighted circles indicate ABCB5 non-synonymous cSNPs. TOPO2 was used to display annotated
results. B. Topological model of predicted ABCB5.ts (full length) protein structure The model incorporates 23 ABCB5 non-synonymous
cSNPs highlighted in black circles.
doi:10.1371/journal.pone.0016318.g004
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tion of ABCB5 has been maintained throughout mammalian
evolution.
The Spidermonkey analysis of the full-length ABCB5 gene
returned a pair of residues with a posterior probability of 0.95 of
co-evolving. These residues, 444 and 1196 on the human full-
length transcript, are in the predicted first and second NBDs,
respectively, and thus may be important for interactions between
these two domains.
Discussion
We have shown in this study that according to topological
structure, ABCB5.ts (the full transporter) could be a functional
form of ABCB5 and demonstrates the conventional 2-TMD and
2-NBD arrangement generally found in full transporters. Each of
these TMDs was determined to contain 6 transmembrane helices
using HMMTOP software. We also found 2 potential N-
glycosylation sites located in the extracellular loops, which may
Table 1. Non-synonymous SNPs in the coding region of ABCB5 beta.
rs NUMBER SNP POSITION SELECTION POSSIBLE SIGNIFICANCE
rs34603556 1 M-.T Start Neutral Start site (ABCB5 beta)
rs2301641 115 K-.E Pot. NBD1 Purifying Signalling
rs13222448 224 K-.R NBD1& TM1 Neutral Signalling
rs62453384 365 G-.V Extracellular loop 2 Neutral Signalling
rs35885925 460 Q-.H Cyt loop Purifying Potential Coupling helix
rs17143304 470 A-.T Cyt loop Purifying Signalling
rs6461515 525 E-.K TM 6 Purifying Potential Substrate site
rs60197951 648 I-.T NBD2 Neutral NBD Str/Funct./Sig.
rs59334881 679 E-.K NBD2 Purifying NBD Str./Funct./Sig.
rs58795451 742 D-.G NBD2, D loop Purifying Communication between ATP sites
doi:10.1371/journal.pone.0016318.t001
Table 2. Non-synonymous cSNPs (23) in the coding region of ABCB5 Full length (.ts).
rs NUMBER SNP POSITION POSSIBLE SIGNIFICANCE
rs78309031 20 A-.E Cytoplasmic loop Signaling
rs74552040 66 P-.L TM1 Potential substrate site
rs17143212 131 T-.I Cytoplasmic loop Signaling
rs77409024 155 F-.V Cytoplasmic loop Signaling
rs61741891 260 R-.K Cytoplasmic loop Potential Coupling helix
rs2074000 262 Q-.K Cytoplasmic loop Potential Coupling helix
rs58976125 369 I-.V NBD1 NBD Structure/Function/Signaling
rs61732039 370 D-.G NBD1 NBD Structure/Function/Signaling
rs34603556 446 M-.T NBD1 NBD Structure/Function/Signaling
rs2301641 560 K-.E NBD1 NBD Structure/Function/Signaling
rs76179099 626 K-. X NBD1 Truncated protein
rs13222448 669 K-.R NBD1 NBD Structure/Function/Signaling
rs62453384 810 G-.V Cytoplasmic loop Signaling
rs80123476 857 A-.T TM 10 Potential substrate site
rs35885925 905 Q-.H Cytoplasmic loop Potential Coupling helix
rs17143304 915 A-.T Cytoplasmic loop Potential Coupling helix
rs6461515 970 E-.K TM12 Potential substrate site
rs78765004 996 P-.Q NBD2 NBD Structure/Function/Signaling
rs80059838 1054 C-.W NBD2 NBD Structure/Function/Signaling
rs74333743 1056 K-.E NBD2 NBD Structure/Function/Signaling
rs60197951 1093 I-.T NBD2 NBD Structure/Function/Signaling
rs59334881 1124 E-.K NBD2 NBD Structure/Function/Signaling
rs58795451 1187 D-.G NBD2/D loop Communication between ATP sites
doi:10.1371/journal.pone.0016318.t002
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membrane. On the other hand, the ABCB5 beta form
demonstrates a rather unconventional structure consisting of 2
potential NBDs and 1 potential TMD, suggesting that: (i) this
transporter might have a unique catalytic cycle; (ii) some
mechanism of post-translational modification may function to
potentially edit the beta form into a more conventional structure to
give rise to the functional form of the transporter; or finally (iii) this
protein may have some function in addition to transport.
Ten non-synonymous cSNPs were found on ABCB5 beta. Of
these, one SNP, rs6461515, maps to the potential substrate site (of
the protein), suggesting that it may play a role in substrate
specificity. We also found this SNP to be slightly more prevalent in
South American populations when compared to other populations
in the Human Genome Diversity Panel (unpublished data from
our laboratory). The rest of these SNPs were in diverse regions of
the transporter, including the NBDs. rs58795451, which is in the
D-loop of the protein, was determined to be the most deleterious
substitution, which agrees well with the fact that the D-loop plays
an important role in communication between the NBDs of ABC
transporters. The ABCB5.ts (full transporter) has 23 non-
synonymous cSNPs, which map to different functional regions of
the putative transporter. rs76179099, which maps to the first
nucleotide binding domain of the protein, would cause a stop
codon to be inserted in this position and may cause the premature
translational termination of this ABC protein.
From phylogenetic and evolutionary analyses, we have shown
that ABCB5 evolved as a full transporter for most of its
evolutionary history. There is an absence of any major shifts in
selection between the various lineages, which would suggest that
the function of ABCB5 has been maintained throughout
mammalian evolution. The full transporter form shows similar
patterns of site-specific selection when compared to the other B-
family full transporters with high levels of purifying selection in
both TMDs and NBDs. This indicates that these motifs have
retained functional significance throughout mammalian evolution.
The full length predicted form in humans also retains these motifs,
suggesting that this could be the functional form with respect to
normal physiology. However, this form of the transporter has
extremely restricted expression in humans (it has only been
documented in the testis) [17] leading to the speculation that
ABCB5 beta which has been reported to be the predominant form
in melanoma and other cancers may possibly undergo dimeriza-
tion to create the physiologically relevant transporter in these
malignancies. The fact that ABCB5 beta has been implicated in
doxorubicin transport in melanoma cells [9] and also in
hepatocellular carcinoma cells [13] lends support to this theory.
Materials and Methods
Protein Informatics
The HMMTOP program was used to predict the topological
structure of ABCB5, using the constraint that the 2
nd NBD was
located in the cytoplasmic region (www.enzim.hu/hmmtop/). This
program operates based on the hypothesis that the topology and
localization of the transmembrane segments is determined, not by
the specific amino acid composition of the various parts of the
protein, but by the amino acid distributions in various regions of
the structure [27]. The output of HMMTOP was displayed using
the TOPO2 transmembrane protein display software (www.sacs.
ucsf.edu/TOPO2/). TMHMM v2 program (www.cbs.dtu.dk/
services/TMHMM/) was used to compute the hydrophobicity
plots using the hidden Markov model [28]. The functional motifs
on the transporter were detected by using the web-based program
MOTIFSCAN (http://hits.isb-sib.ch/cgi-bin/PFSCAN), which is
primarily a data retrieval and analysis system that can match
protein sequences to precomputed patterns and profiles from Pfam
and Prosite [29,30].
Marcoil (www.isrec.isb-sib.ch/webmarcoil/webmarcoilC1.html)
[31] and COILS (www.ch.embnet.org/software/COILS_form.
html) were used to predict coiled–coil domains. COILS is a program
that compares a particular sequence to a database of known parallel
two-stranded coiled–coils and computes a similarity score. On
comparing this score to the distribution of scores in globular and
coiled–coil proteins, the program then calculates the probability that
the sequence will adopt a coiled–coil conformation [32].
Table 4. In silico prediction of functional significance of
ABCB.ts non-synonymous cSNPs calculated using Panther.
Substitution subPSEC score
P66L 25.10163
T131I 23.1368
F155V 27.05629
R260K 22.69866
Q262K 23.89135
I369V 23.98202
D370G 24.70914
M446T 23.64169
K560E 26.12726
K669R 23.1384
G810V 24.6663
A857T 22.52579
Q905H 24.03142
A915T 23.86813
E970K 22.81761
P996Q 4.62436
C1054W 28.89455
I1093T 24.64248
E1124K 23.58989
D1187G 26.60494
doi:10.1371/journal.pone.0016318.t004
Table 3. In silico prediction of functional significance of
ABCB5 beta non-synonymous cSNPs calculated using Panther.
Substitution subPSEC score
M1T 25.39815
K115E 26.47709
K224R 24.39767
G365V 23.93172
Q460H 24.45293
A470T 24.2594
E525K 24.30042
I648T 26.31679
E679K 24.85185
D742G 28.71012
doi:10.1371/journal.pone.0016318.t003
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PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16318Figure 5. Phylogeny of the ABCB full transporters. The tree is a maximum likelihood phylogram, with Bayesian posterior probabilities
(expressed as percentages). Support for each node is 100% unless otherwise indicated. Abbreviated species names are as follows; Hsap = Homo
sapiens, Ptro = Pan troglodytes, Ppyg = Pongo pygmaeus, Mmul = Macaca mulatta, Mmur = Microcebus murinus, Ogar = Otolemur garnettii, Tbel =
Tupaia belangeri, Stri = Spermophilus tridecemlineatus, Mmus = Mus musculus, Rnor = Rattus norvegicus, Cpor = Cavia porcellus, Opri = Ochotona
princeps, Ocun = Oryctolagus cuniculus, Btau = Bos taurus, Ecab = Equus caballus, Cfam = Canis familiaris, Fcat = Felis catus, Mluc = Myotis
lucifugus, Eeur = Erinaceus europaeus, Sara = Sorex araneus, Lafr = Loxodonta africanus, Etel = Echinops telfairi, Dnov = Dasypus novemcinctus,
Mdom = Monodelphis domestica, Oana = Ornithorhynchus anatinus, Ggal = Gallus gallus, Xtro = Xenopus tropicalis, Drer = Danio rerio, Trub =
Takifugu rubripes, Tnig = Tetraodon nigroviridis, Gacu = Gasterosteus aculeatus, Olat = Oryzias latipes, Csar = Ciona savignyi, Cint = Ciona intestinalis.
Letters after the species name refer to the gene sequence, with an additional ‘‘l’’ indicating that the gene is not a direct ortholog, e.g., XtroB1l is a B1
‘‘like’’ gene.
doi:10.1371/journal.pone.0016318.g005
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to verify that the regions were actually coiled–coils [33]. This
program is used to predict protein secondary structure and is based
on position-specific scoring matrices created by PSI-BLAST [34].
Single Nucleotide Polymorphism Analysis
The predicted functional significance of the amino acid
substitutions was calculated using Panther software (www.
pantherdb.org) and SIFT (http://sift.jcvi.org). Panther estimates
the likelihood of a particular nonsynonymous (amino acid-
changing) coding SNP to cause a functional impact on the
protein. It calculates the subPSEC (substitution position-specific
evolutionary conservation) score based on an alignment of
evolutionarily related proteins. Then it scores the likelihood of a
single amino acid at a particular position (amino acid PSEC/
aaPSEC) or the likelihood of the transition of one amino acid to
Figure 6. The level of selection operating on each site of the ABCB5 sequence. Selecton output showing the level of selection on human
ABCB5. Orange residues indicate an v value greater than 1, suggesting positive selection, while dark purple residues have an v value significantly
lower than 1, indicating strong purifying selection.
doi:10.1371/journal.pone.0016318.g006
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PLoS ONE | www.plosone.org 10 January 2011 | Volume 6 | Issue 1 | e16318another (substitution PSEC, subPSEC). When aaPSEC =0, this is
the evolutionarily most common allele (inferred to be definitely
functional), whereas more negative values of aaPSEC indicate that
the allele is less likely to be observed across evolution (inferred to
be less likely to conserve function). The subPSEC score is the
difference between the aaPSEC scores for the two alleles. The
algorithm takes the absolute value in order to make the scores
symmetric, and then multiplies by –1 to adhere to the substitution
matrix convention that more negative scores correspond to more
severe substitutions. When subPSEC =0, the substitution is
interpreted as functionally neutral, whereas more negative values
of subPSEC predict more deleterious substitutions. The cutoff
subPSEC , –3 indicates a deleterious substitution [35]. SIFT uses
a sequence homology based approach to classify the substitutions
in amino acids. A highly conserved amino acid would be
considered to be intolerant to most substitutions while a poorly
conserved position would tolerate the majority of substitutions
[36].
Phylogenetic and Evolutionary Analysis
Amino acid and nucleotide sequences of each ABCB gene for
each species were downloaded from the Ensembl database (http://
www.ensembl.org). If more than one transcript was available, the
longest transcript was chosen. Alignments were constructed on the
amino acid sequences with the online MAFFT server (http://
align.bmr.kyushu-u.ac.jp/mafft/online/server/index.html), using
the G-INS-i setting [37]. Protein alignments were converted into
nucleotide alignments using the online PAL2NAL server (http://
www.bork.embl.de/pal2nal/) [38]. A Bayesian phylogeny based
on the nucleotide alignment of the complete ABCB family was
constructed using MrBayes [39]. The nucleotide model used was a
General Time Reversible model with 6 substitution rate
parameters and gamma-distributed rate variation with a propor-
tion of invariant sites. The analysis was run for 4 million
generations,10 with a sample frequency of 100 and burn-in set
to 10,000 (which corresponded to 25% of the sampled trees).
Selection analyses were performed on PAML v4.1 [40],
DataMonkey (http://www.datamonkey.org/) [41] and Selecton
(http://selecton.tau.ac.il/) [42]. Site selection analyses were based
on the ratio of the rate of non-synonymous substitutions per non-
synonymous site (Ka) to the rate of synonymous substitutions per
synonymous site (Ks). This is used as an indicator of the level of
selective pressure acting on a protein-coding gene, with values of
less than 1 indicative of purifying selection, while values greater
than 1 suggest positive selection. Analyses were performed in
PAML by comparing a model with one-rate category to a model
that added a neutral rate category and then to a 3
rd model that
added a category for positively selected sites. In DataMonkey, the
Random Effects Likelihood (REL) method was used to estimate
the Ka/Ks value for each codon.
In Selecton, the mechanistic-empirical combined (MEC) model
was used, which takes into account differences between amino-
acid replacement probabilities, under the assumption that more
radical changes in amino acid type represent a larger evolutionary
step. The GABranch algorithm in DataMonkey was used to
measure changes in selective pressure acting along different
lineages. The Spidermonkey analysis of DataMonkey was used
to infer sites with conditional evolutionary dependencies indicating
pairs of sites that may have a functional or structural importance.
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